|
시장보고서
상품코드
2055300
유전성 질환 검사 시장 : 검사 유형별, 기술별, 용도별, 환자 연령층별, 최종사용자별, 지역별Hereditary Testing Market, By Test Type, By Technology, By Application, By Patient Age Group, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전성 질환 검사 시장은 2026년 85억 달러로 추정되며, 2033년까지 152억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 85억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.70% | 2033년 시장 규모 예측 : | 152억 2,000만 달러 |
세계 유전성 질환 검사 시장은 유전자 기술의 발전과 질환의 조기 발견 및 예방의 중요성에 대한 인식 제고를 배경으로, 최근 몇 년간 눈부신 성장을 이루고 있습니다. 유전성 질환 검사는 개인의 DNA를 분석하여 특정 유전성 질환 발병 위험을 높일 수 있는 유전적 변이를 확인하는 것입니다. 이 시장에는 암, 심혈관 질환, 신경계 질환, 희귀 유전성 질환 등 광범위한 유전자 검사가 포함됩니다. 질병의 유전적 기전에 대한 이해가 깊어짐에 따라 유전자 검사에 대한 수요가 증가할 것으로 예상되며, 이는 시장 성장을 견인할 것입니다. 또한, 일반 소비자용 유전자 검사 키트의 보급과 맞춤형 의료 접근법의 확대도 시장 성장에 크게 기여하고 있습니다.
시장 역학
세계 유전성 질환 검사 시장은 몇 가지 주요 시장 성장 촉진요인, 억제요인 및 기회의 영향을 받고 있습니다. 주요 시장 성장 요인 중 하나는 전 세계 유전성 질환 유병률 증가이며, 이에 더해 조기 발견과 예방의 중요성에 대한 인식 제고도 꼽을 수 있습니다. 차세대 염기서열 분석(NGS) 등 유전자 염기서열 분석 기술의 발전으로 유전자 검사가 더욱 이용하기 쉬워지고 가격도 저렴해지면서 시장 성장을 더욱 촉진하고 있습니다. 또한, 유전자 정보를 활용해 치료 계획을 개인화하는 맞춤형 의료 접근법의 확대는 유전성 질환 검사 시장에 큰 기회를 제공합니다. 그러나 시장에는 유전자 검사의 높은 비용, 제한적인 보험 급여 제도, 그리고 유전 정보의 사생활 보호 및 차별과 관련된 윤리적 우려 등 몇 가지 제약 요인도 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 유전자 검사 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 유전성 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 유전성 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 유전성 질환 검사 시장 : 테스트 유형별, 2021년-2033년
제5장 세계의 유전성 질환 검사 시장 : 기술별, 2021년-2033년
제6장 세계의 유전성 질환 검사 시장 : 용도별, 2021년-2033년
제7장 세계의 유전성 질환 검사 시장 : 환자 연령층별, 2021년-2033년
제8장 세계의 유전성 질환 검사 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 유전성 질환 검사 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.23Hereditary Testing Market is estimated to be valued at USD 8.50 Bn in 2026 and is expected to reach USD 15.22 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.50 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.70% | 2033 Value Projection: | USD 15.22 Bn |
The global hereditary testing market has witnessed significant growth in recent years, driven by advancements in genetic technology and increasing awareness about the importance of early disease detection and prevention. Hereditary testing involves analyzing an individual's DNA to identify genetic variations that may increase the risk of developing certain inherited disorders. This market encompasses a wide range of genetic tests, including those for cancer, cardiovascular diseases, neurological disorders, and rare genetic conditions. As the understanding of the genetic basis of diseases continues to expand, the demand for hereditary testing is expected to rise, fueling market growth. Moreover, the increasing availability of direct-to-consumer genetic testing kits and the growing adoption of personalized medicine approaches are further contributing to the market's expansion.
Market Dynamics
The global hereditary testing market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of genetic disorders worldwide, coupled with the rising awareness about the importance of early detection and prevention. Advancements in genetic sequencing technologies, such as next-generation sequencing (NGS), have made genetic testing more accessible and affordable, further driving market growth. Moreover, the growing adoption of personalized medicine approaches, which rely on genetic information to tailor treatment plans, is creating significant opportunities for the hereditary testing market. However, the market also faces certain restraints, such as the high cost of genetic testing, limited reimbursement policies, and ethical concerns surrounding genetic privacy and discrimination.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global hereditary testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Fulgent Genetics, Inc., Genomic Health, Inc., Invitae Corporation, Roche Diagnostics, Siemens Healthineers, BGI Genomics, Quest Diagnostics, PerkinElmer, Inc., Eurofins Scientific, ArcherDX, and Color Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global hereditary testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hereditary testing market
Market Segmentation
- Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Predictive Testing
- Diagnostic Testing
- Carrier Testing
- Prenatal Testing
- Newborn Screening
- Preimplantation Genetic Diagnosis (PGD)
- Pharmacogenomic Testing
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Array Comparative Genomic Hybridization (aCGH)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiovascular Diseases
- Neurology
- Metabolic Disorders
- Rare Diseases
- Reproductive Health
- Others
- Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Research Institutions
- Home Care Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Myriad Genetics, Inc.
- Agilent Technologies, Inc.
- Fulgent Genetics, Inc.
- Genomic Health, Inc.
- Invitae Corporation
- Roche Diagnostics
- Siemens Healthineers
- BGI Genomics
- Quest Diagnostics
- PerkinElmer, Inc.
- Eurofins Scientific
- ArcherDX
- Color Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Hereditary Testing Market, By Test Type
- Global Hereditary Testing Market, By Technology
- Global Hereditary Testing Market, By Application
- Global Hereditary Testing Market, By Patient Age Group
- Global Hereditary Testing Market, By End User
- Global Hereditary Testing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Hereditary Testing Market, By Test Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Predictive Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Carrier Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Preimplantation Genetic Diagnosis (PGD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pharmacogenomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Hereditary Testing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Array Comparative Genomic Hybridization (aCGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Hereditary Testing Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Hereditary Testing Market, By Patient Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Hereditary Testing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Hereditary Testing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fulgent Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genomic Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ArcherDX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Color Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
